Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition

Published year

2019

Authors

Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J.

Abstract

PubMed

Full text (subscription may be required)

Wiley

Additional Information

Cochrane Database of Systematic Reviews 2019;(1):CD009768.